Effects of ZD0947, a novel and potent ATP-sensitive K⁺ channel opener, on smooth muscle-type ATP-sensitive K⁺ channels

详细信息    查看全文

• 作者：Keisuke Mori^a ; ^b ; Yoshio Yamashita^b ; Noriyoshi Teramoto^a ; ^c ; ^{noritera@cc.saga-u.ac.jp" class="auth_mail" title="E-mail the corresponding author}
• 关键词：ATP-sensitive K+ channels ; K+ channel opener ; Smooth muscle ; ZD0947
• 刊名：European Journal of Pharmacology
• 出版年：2016
• 出版时间：15 November 2016
• 年：2016
• 卷：791
• 期：Complete
• 页码：773-779
• 全文大小：846 K

文摘

The effects of ZD0947, a novel ATP-sensitive K⁺ channel (K_ATP channel) opener, on the activity of reconstituted K_ATP channels were investigated using cell-attached recordings. K_ATP channels were studied in HEK 293 cells by co-expression of inwardly rectifying-6 family K⁺ channel subunits (Kir6.x: Kir6.1 and Kir6.2) with 3 different types of sulphonylurea receptors (SUR.x: SUR1, SUR2A and SUR2B). ZD0947 (100 µM) activated SUR2B/Kir6.2 channels in a concentration-dependent manner, but caused only weak activation of SUR1/Kir6.2 channels and SUR2A/Kir6.2 channels expressed in HEK 293 cells. ZD0947 reversibly suppressed diazoxide-elicited SUR1/Kir6.2 channels activity and pinacidil-elicited SUR2A/Kir6.2 channel activity. However, ZD0947 did not affect SUR2B/Kir6.2 channels fully activated by 100 µM pinacidil. ZD0947 had little inhibitory effects on the activity of Kir6.2ΔC26 channels (a truncated isoform of Kir6.2) or its mutant channels (i.e. Kir6.2ΔC26C166A) expressed in HEK 293 cells. ZD0947 also elicited activity in SUR2B/Kir6.1 channels expressed in HEK 293 cells, in a concentration-dependent manner. Therefore, ZD0947 is a relatively effective activator of smooth muscle-type K_ATP channels (SUR2B/Kir6.1 and SUR2B/Kir6.2) but is a partial antagonist of pancreatic-type K_ATP channels (i.e. SUR1/Kir6.2) and cardiac-type K_ATP channels (i.e. SUR2A/Kir6.2). These results suggest that a pharmacological agent can possess either agonist or antagonist actions on the activity of K_ATP channels, depending on the subtype of SUR.x.